FLYNN PATRICK JOHN purchased 11.75K shares of NRX PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $14.7K. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 11/29/2022ACC: 0001415889-22-011810
Director
Since May 2021
+11.75K
Net shares
Net buyer
$14.7K
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
11.75K acquired
Non-Derivative Transactions5
Common Stock, par value $0.001 per share
Indirect
Shares
+2.50K
Price / share
$1.25
Trade value
$3.13K
% of position
7.1%
11/28/2022
35.21K→37.71K
Common Stock, par value $0.001 per share
Indirect
Shares
+2.50K
Price / share
$1.25
Trade value
$3.13K
% of position
6.6%
11/28/2022
37.71K→40.21K
Common Stock, par value $0.001 per share
Indirect
Shares
+2.50K
Price / share
$1.25
Trade value
$3.13K
% of position
7.1%
11/28/2022
35.21K→37.71K
Common Stock, par value $0.001 per share
Indirect
Shares
+2.50K
Price / share
$1.24
Trade value
$3.10K
% of position
6.6%
11/28/2022
37.71K→40.21K
Common Stock, par value $0.001 per share
Direct
Shares
+1.75K
Price / share
$1.25
Trade value
$2.19K
% of position
New position
11/28/2022
0.00→1.75K
Total
Net shares
+11.75K
Net value
$14.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share Indirect | 11/28/2022 | P · Purchase | +2.50K | $1.25 | $3.13K | 7.1% | 35.21K | 37.71K |
| Common Stock, par value $0.001 per share Indirect | 11/28/2022 | P · Purchase | +2.50K | $1.25 | $3.13K | 6.6% | 37.71K | 40.21K |
| Common Stock, par value $0.001 per share Indirect | 11/28/2022 | P · Purchase | +2.50K | $1.25 | $3.13K | 7.1% | 35.21K | 37.71K |
| Common Stock, par value $0.001 per share Indirect | 11/28/2022 | P · Purchase | +2.50K | $1.24 | $3.10K | 6.6% | 37.71K | 40.21K |
| Common Stock, par value $0.001 per share Direct | 11/28/2022 | P · Purchase | +1.75K | $1.25 | $2.19K | New position | 0.00 | 1.75K |
| Total | +11.75K | $14.66K | ||||||
Derivative Transactions0
No derivative transactions reported